340 related articles for article (PubMed ID: 11472076)
1. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men.
Gibney J; Wolthers T; Johannsson G; Umpleby AM; Ho KK
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E266-71. PubMed ID: 15727949
[TBL] [Abstract][Full Text] [Related]
4. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
9. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
10. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
Rasmussen MH; Juul A; Hilsted J
Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
[TBL] [Abstract][Full Text] [Related]
13. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
14. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
15. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
16. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
18. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
[TBL] [Abstract][Full Text] [Related]
19. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
Liang LJ; Luo SM; Hu WJ
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
[TBL] [Abstract][Full Text] [Related]
20. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]